While TP53 mutations themselves occur only in approximately 5–7% of FL, this could indicate other deregulation leading to the loss of tumor suppressor function aside from the commonly known TP53 mutations and/or deletions [5,11,57]. This evidence concerns the gene TP53 and neoplasm.